» Articles » PMID: 24140218

Successes and Challenges of Establishing a Cervical Cancer Screening and Treatment Program in Western Kenya

Overview
Publisher Wiley
Date 2013 Oct 22
PMID 24140218
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the challenges and successes of integrating a public-sector cervical screening program into a large HIV care system in western Kenya.

Methods: The present study was a programmatic description and a retrospective chart review of data collected from a cervical screening program based on visual inspection with acetic acid (VIA) between June 2009 and October 2011.

Results: In total, 6787 women were screened: 1331 (19.6%) were VIA-positive, of whom 949 (71.3%) had HIV. Overall, 206 women underwent cryotherapy, 754 colposcopy, 143 loop electrical excision procedure (LEEP), and 27 hysterectomy. Among the colposcopy-guided biopsies, 27.9% had severe dysplasia and 10.9% had invasive cancer. There were 68 cases of cancer, equating to approximately 414 per 100000 women per year. Despite aggressive strategies, the overall loss to follow-up was 31.5%: 27.9% were lost after a positive VIA screen, 49.3% between biopsy and LEEP, and 59.6% between biopsy and hysterectomy/chemotherapy.

Conclusion: The established infrastructure of an HIV treatment program was successfully used to build capacity for cervical screening in a low-resource setting. By using task-shifting and evidence-based, low-cost approaches, population-based cervical screening in a rural African clinical network was found to feasible; however, loss to follow-up and poor pathology infrastructure remain important obstacles.

Citing Articles

The role of co-infections and hormonal contraceptives in cervical intraepithelial neoplasia prevalence among women referred to a tertiary hospital in Western Kenya.

George Onyango C, Ogonda L, Guyah B Infect Agent Cancer. 2025; 20(1):11.

PMID: 39994762 PMC: 11853817. DOI: 10.1186/s13027-024-00620-4.


Women's experiences and acceptability of self-administered, home delivered, intravaginal 5-Fluorouracil cream for cervical precancer treatment in Kenya.

Adewumi K, Kachoria A, Adoyo E, Rop M, Owaya A, Tang J Front Reprod Health. 2025; 7:1487264.

PMID: 39980670 PMC: 11839715. DOI: 10.3389/frph.2025.1487264.


The Cancer Tracking System (CATSystem): Study protocol of a randomized control trial to evaluate a systems level intervention for cervical cancer screening, treatment, referral and follow up in Kenya.

Maloba M, Finocchario-Kessler S, Wexler C, Staggs V, Maosa N, Babu S PLoS One. 2025; 20(2):e0318941.

PMID: 39965035 PMC: 11835318. DOI: 10.1371/journal.pone.0318941.


Factors that shape the integration of HIV and TB services in Zomba District, Malawi.

Maseko A, Silumbwe A, Maritim P, Munakampe M, Chirambo G, Jacobs C BMC Health Serv Res. 2025; 25(1):213.

PMID: 39915793 PMC: 11800521. DOI: 10.1186/s12913-025-12367-8.


Evaluation of pathology resources for cervical cancer detection between 2018 and 2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.

Anangwe N, Steimgrimson J, Cu-Uvin S BMC Cancer. 2025; 25(1):203.

PMID: 39910487 PMC: 11796189. DOI: 10.1186/s12885-025-13563-9.